• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体β配体结合域在部分激动剂和完全拮抗剂存在时的结构

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.

作者信息

Pike A C, Brzozowski A M, Hubbard R E, Bonn T, Thorsell A G, Engström O, Ljunggren J, Gustafsson J A, Carlquist M

机构信息

Structural Biology Laboratory, Chemistry Department, University of York, York YO10 5DD, UK.

出版信息

EMBO J. 1999 Sep 1;18(17):4608-18. doi: 10.1093/emboj/18.17.4608.

DOI:10.1093/emboj/18.17.4608
PMID:10469641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1171535/
Abstract

Oestrogens exert their physiological effects through two receptor subtypes. Here we report the three-dimensional structure of the oestrogen receptor beta isoform (ERbeta) ligand-binding domain (LBD) in the presence of the phyto-oestrogen genistein and the antagonist raloxifene. The overall structure of ERbeta-LBD is very similar to that previously reported for ERalpha. Each ligand interacts with a unique set of residues within the hormone-binding cavity and induces a distinct orientation in the AF-2 helix (H12). The bulky side chain of raloxifene protrudes from the cavity and physically prevents the alignment of H12 over the bound ligand. In contrast, genistein is completely buried within the hydrophobic core of the protein and binds in a manner similar to that observed for ER's endogenous hormone, 17beta-oestradiol. However, in the ERbeta-genistein complex, H12 does not adopt the distinctive 'agonist' position but, instead, lies in a similar orientation to that induced by ER antagonists. Such a sub-optimal alignment of the transactivation helix is consistent with genistein's partial agonist character in ERbeta and demonstrates how ER's transcriptional response to certain bound ligands is attenuated.

摘要

雌激素通过两种受体亚型发挥其生理作用。在此,我们报道了在植物雌激素染料木黄酮和拮抗剂雷洛昔芬存在的情况下,雌激素受体β亚型(ERβ)配体结合域(LBD)的三维结构。ERβ-LBD的整体结构与先前报道的ERα非常相似。每种配体与激素结合腔内一组独特的残基相互作用,并在AF-2螺旋(H12)中诱导出不同的取向。雷洛昔芬的庞大侧链从腔内突出,从物理上阻止H12在结合配体上的排列。相比之下,染料木黄酮完全埋藏在蛋白质的疏水核心内,其结合方式与ER的内源性激素17β-雌二醇相似。然而,在ERβ-染料木黄酮复合物中,H12并未采取独特的“激动剂”位置,而是处于与ER拮抗剂诱导的取向相似的位置。反式激活螺旋的这种次优排列与染料木黄酮在ERβ中的部分激动剂特性一致,并证明了ER对某些结合配体的转录反应是如何减弱的。

相似文献

1
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.雌激素受体β配体结合域在部分激动剂和完全拮抗剂存在时的结构
EMBO J. 1999 Sep 1;18(17):4608-18. doi: 10.1093/emboj/18.17.4608.
2
Molecular basis of agonism and antagonism in the oestrogen receptor.雌激素受体激动作用和拮抗作用的分子基础
Nature. 1997 Oct 16;389(6652):753-8. doi: 10.1038/39645.
3
Structural aspects of agonism and antagonism in the oestrogen receptor.雌激素受体激动和拮抗作用的结构方面
Biochem Soc Trans. 2000;28(4):396-400.
4
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.一种亚型选择性配体的结构表征揭示了雌激素受体拮抗作用的新模式。
Nat Struct Biol. 2002 May;9(5):359-64. doi: 10.1038/nsb787.
5
Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment.小鼠雌激素受体β亚型在配体选择性和共激活因子募集方面存在差异。
Biochemistry. 2005 Jun 7;44(22):7936-44. doi: 10.1021/bi047691m.
6
Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.使用稳定表达雌激素受体α或β的报告细胞系评估配体选择性。
Biochem Pharmacol. 2006 May 14;71(10):1459-69. doi: 10.1016/j.bcp.2006.02.002. Epub 2006 Mar 22.
7
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.雌激素受体:选择性配体、伴侣蛋白及独特的药理学特性
Recent Prog Horm Res. 2000;55:163-93; discussion 194-5.
8
Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.简单化的异黄酮——染料木黄酮对β型雌激素受体的激动活性介导了它们的健康益处。
Med Hypotheses. 2006;66(6):1093-114. doi: 10.1016/j.mehy.2004.11.046. Epub 2006 Mar 2.
9
Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.雌激素受体配体解离机制及选择性的计算洞察
J Phys Chem B. 2009 Jul 30;113(30):10436-44. doi: 10.1021/jp903785h.
10
Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.雌激素相关受体α配体结合域及其与配体和共激活因子复合物结构的小角X射线散射研究
J Phys Chem B. 2008 Aug 14;112(32):9603-12. doi: 10.1021/jp800120r. Epub 2008 Jul 23.

引用本文的文献

1
Secondary Metabolites of the Marine Sponge-Derived Fungus 1901NT-1.40.2 and Their Antimicrobial and Anticancer Activities.海洋海绵来源真菌1901NT-1.40.2的次生代谢产物及其抗菌和抗癌活性
Mar Drugs. 2025 Aug 30;23(9):353. doi: 10.3390/md23090353.
2
Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy.大豆苷元和染料木黄酮:在激素替代疗法中具有潜在应用价值的天然植物雌激素。
Int J Mol Sci. 2025 Jul 20;26(14):6973. doi: 10.3390/ijms26146973.
3
Look What You Made Me Do: Discerning Feature for Classification of Endocrine-Disrupting Chemical Binding to Steroid Hormone Receptors.看看你让我做了什么:用于识别内分泌干扰化学物质与类固醇激素受体结合的分类特征。
J Chem Inf Model. 2025 Apr 28;65(8):4148-4162. doi: 10.1021/acs.jcim.4c02288. Epub 2025 Apr 8.
4
Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor.雌激素通过雌激素受体β在乳腺癌中发挥信号作用;自该受体被发现以来我们所了解到的情况。
Receptors (Basel). 2024 Jun;3(2):182-200. doi: 10.3390/receptors3020010. Epub 2024 May 3.
5
Protein Structure-Based Organic Chemistry-Driven Ligand Design from Ultralarge Chemical Spaces.基于蛋白质结构的有机化学驱动的超大型化学空间配体设计
ACS Cent Sci. 2024 Feb 13;10(3):615-627. doi: 10.1021/acscentsci.3c01521. eCollection 2024 Mar 27.
6
Synergistic Anti-Cancer Effects of ERB-041 and Genistein through Estrogen Receptor Suppression-Mediated PI3K/AKT Pathway Downregulation in Canine Mammary Gland Tumor Cells.ERB-041与染料木黄酮通过抑制雌激素受体介导的PI3K/AKT信号通路下调对犬乳腺肿瘤细胞的协同抗癌作用
Int J Mol Sci. 2024 Feb 20;25(5):2466. doi: 10.3390/ijms25052466.
7
Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research.三阴性乳腺癌中雌激素受体β亚型的不同特征:研究进展及对进一步研究的启示
Front Cell Dev Biol. 2023 Oct 23;11:1240386. doi: 10.3389/fcell.2023.1240386. eCollection 2023.
8
Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes: an exploration of new perspectives for anticancer chemotherapeutics.构建具有生物活性的多种功能化双环[3.3.1]壬烷的不同途径:抗癌化疗新视角探索
RSC Adv. 2023 Jul 25;13(32):22389-22480. doi: 10.1039/d3ra02003g. eCollection 2023 Jul 19.
9
An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management.他莫昔芬与维生素E在乳腺癌治疗中的化学预防潜力的最新进展。
J Pers Med. 2023 Apr 28;13(5):754. doi: 10.3390/jpm13050754.
10
Efficacy and Safety of the Genistein Nutraceutical Product Containing Vitamin E, Vitamin B3, and Ceramide on Skin Health in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.含维生素E、维生素B3和神经酰胺的金雀异黄素营养产品对绝经后女性皮肤健康的疗效和安全性:一项随机、双盲、安慰剂对照临床试验
J Clin Med. 2023 Feb 7;12(4):1326. doi: 10.3390/jcm12041326.